Oral Minoxidil

Oral Minoxidil is a low-dose oral medication used to stimulate hair growth in cases unresponsive to topical treatments. While the commonly recognized topical minoxidil solution or foam is applied directly to the scalp, oral minoxidil is typically prescribed at much lower dosages, often starting from 0.25 mg to 1.25 mg daily for women and 2.5 mg to 5 mg daily for men. This systemic delivery allows the active ingredient, minoxidil sulfate, to reach hair follicles throughout the scalp more uniformly, promoting vasodilation and stimulating hair growth by prolonging the anagen (growth) phase of the hair cycle and shortening the telogen (resting) phase. Its efficacy is particularly noted in patients who have not responded adequately to topical minoxidil, or who experience scalp irritation or convenience issues with the topical form.

The significance of oral minoxidil to a patient's hair restoration journey often lies in its potential to augment the results of a hair transplant or to serve as a standalone treatment for diffuse thinning. For transplant patients, it can enhance the survival and growth of transplanted follicles, as well as strengthen existing native hairs, contributing to a denser overall appearance. This is especially relevant in cases of advanced androgenetic alopecia where ongoing miniaturization of native hairs could otherwise diminish the long-term aesthetic outcome. Its systemic action can also benefit hair growth in other body areas, though this is generally considered a minor side effect rather than a primary goal for scalp hair restoration.

Patients can generally expect to observe initial changes within three to six months of consistent use, with peak effects often seen around 12 to 18 months. Hair shedding, known as "minoxidil-induced telogen effluvium," can occur in the first few weeks or months of treatment as existing resting hairs are pushed out to make way for new growth; this is a temporary and often reassuring sign of the medication beginning to work. The typical improvement in hair density can range from a noticeable reduction in shedding and increased thickness of individual strands to a significant increase in overall hair count, measurable in scientific studies as an increase of 10-30 hairs per square centimeter in some responsive individuals.

Despite its benefits, potential side effects are a critical consideration. Hypertrichosis, or increased hair growth on unwanted body areas such as the face, arms, and back, is the most common side effect, often reported in up to 50% of patients depending on dosage. Other less frequent but more serious side effects include lightheadedness, dizziness, fluid retention, and mild changes in blood pressure or heart rate, particularly at higher doses. These cardiovascular effects are generally rare at the low doses used for hair loss but necessitate careful monitoring, especially in patients with pre-existing conditions. Many Turkish clinics, recognizing the medication's efficacy and potential side effects, often prescribe oral minoxidil as part of a comprehensive post-operative care package, sometimes in conjunction with other treatments like Finasteride or Dutasteride.

When considering oral minoxidil, a patient should thoroughly discuss their medical history with the prescribing doctor. Key questions to ask include the specific dosage recommended, the potential for side effects given their individual health profile, and how often follow-up appointments will be needed to monitor progress and manage any adverse reactions. Patients should confirm if any pre-existing conditions, such as hypertension or heart disease, might preclude its use or require additional precautions. It is also crucial to inquire about the duration of treatment, as oral minoxidil, like topical minoxidil, typically requires continuous use to maintain its benefits; cessation often leads to a gradual loss of the newly grown hair within several months. Understanding these facets ensures a patient makes an informed decision grounded in realistic expectations and safety.